Navigation Links
NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients
Date:12/12/2010

rian cancer and now in metastatic breast cancer.  This clinical benefit we've observed in tumor settings, where a highly active topoisomerase 1 inhibitor could be extremely useful, makes us very excited about the future of NKTR-102."

Side effects were generally manageable with dose-limiting toxicity consisting primarily of Grade 3 diarrhea (20-23%) typically occurring after three months of therapy for both schedules.  Only one patient of 70 patients treated with NKTR-102 experienced Grade 2 alopecia and no patient experienced grade 3 or 4 neuropathy.  Both neuropathy and alopecia are significant adverse events commonly associated with standard breast cancer therapies [Safety Tables, Figures D and E].

SABCS PresentationThe presentation (P6-11-01) made today at the SABCS 2010 meeting can be found on Nektar's website at http://www.nektar.com/product_pipeline/oncology_nktr-102.html:

  • Awada et. al., "Significant Efficacy in a Phase 2 Study of NKTR-102, a Novel Polymer Conjugate of Irinotecan, in Patients with Pre-Treated Metastatic Breast Cancer (MBC)"

  • Nektar to Host Investor and Analyst Call/Webcast During SABCSThe call will include a webcast with slide presentation of the data and a summary review by Howard W. Robin, Nektar President and CEO.  The call will feature a review of the data by Dr. Ahmad Awada, Head of the Medical Oncology Clinic at the Institut Jules Bordet in Brussels, Belgium.  The webcast can be accessed live from the home page of Nektar's website at www.nektar.com.Date and Time:  Sunday, December 12, 2010, 9:00 a.m. – 10:00 a.m. Central Time  To access the audio conference call, follow these instructions:  Dial: 866-713-8310 (U.S.); (617) 597-5308 (international) Passcode: 36236932 (Nektar is the host)To access the live webcast, please log
    '/>"/>

    SOURCE Nektar Therapeutics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
    2. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
    3. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
    4. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
    5. Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
    6. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
    7. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
    8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
    9. Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
    10. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
    11. Pevions Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... -- Monarch America Inc. (OTCQB: CANK) ("Monarch America" or the ... this review of the Company,s recent achievements and strategic ... this past year, we achieved many of our early ... say that Monarch America is in a stronger and ... stated Eric Hagen , CEO of Monarch America ...
    (Date:12/19/2014)... Texas , December 18, 2014 ... networked software application/module that is used to store, ... images. RIS comprises a patient tracking and scheduling ... The integration of RIS with HIS and other ... for patient registration and patient scheduling, patient list ...
    (Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/942kh3/micro_market ... "Micro Market Monitor: North American Dermatology Diagnostic Devices ... http://photos.prnewswire.com/prnh/20130307/600769 Cosmetic ... has resulted in fueling the overall demand of ... of these dermatology devices is to assist in ...
    Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
    (Date:12/22/2014)... Coral Gables, FL (PRWEB) December 22, 2014 ... head lice removal service , Lice Troopers, with its new ... established in southern Florida, takes the hassle out of dealing ... removal services in one of their two salon clinic locations ... home or other location. , The decision to expand developed ...
    (Date:12/22/2014)... December 22, 2014 The holidays are here, ... the season. Many may be thinking about how to enjoy ... a few weeks. Health Republic Insurance of New York has ... Andrea Chernus, to provide some smart ideas to enjoy the ... , 1)    Avoid arriving at a holiday gathering over-hungry , Have ...
    (Date:12/22/2014)... China (PRWEB) December 22, 2014 Physicians ... MabThera (rituximab) for the treatment of non-Hodgkin’s lymphoma (NHL), ... , a leading global healthcare consulting firm. MabThera is ... lymphoma (DLBCL), the most common form of NHL. , ... Access and Barriers,” the incidence of NHL in China ...
    (Date:12/22/2014)... December 22, 2014 Only weeks following ... and mid-western cities to have a battery manufacturer create ... ( http://www.talklocal.com ) is launching in Henderson ... , “A strong manufacturing sector is going to ... Gurpreet Singh explained, “and TalkLocal works with small businesses ...
    (Date:12/22/2014)... Pasadena sleep apnea dentist, Dr. Marine ... drivers are 15 times more likely to cause deadly ... experts believe that sleep-deprived drivers may be just as ... of Americans may be sleep-deprived without even knowing it. ... 18 million Americans have sleep apnea, but as many ...
    Breaking Medicine News(10 mins):Health News:Professional In-Home All-Natural Lice Removal Service Expands to Coral Gables and surrounding areas. 2Health News:Health Republic Insurance of New York Offers Five Simple Tips to Eat Healthy During the Holidays 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2
    ... network for the NHS, that would cost ?300 million. // ... of IT companies comprising of Atos Origin, BT, IBM, and ... NHS with national computer services for 11 years. ... and nurse rosters. ,The consortium has decided to ...
    ... a rather unique show of exemplary medical prowess and ... John Hopkins //Comprehensive Transplant Center. This maiden feat was ... and 18 nurses and it took place over 10 ... the hospital has confirmed the good health of the ...
    ... Foundation's Health Literacy Conference reports on the relationship between ... patients could not explain why they take the prescribed ... should they take them. About half of the ... the research. ,Low health literacy is the ...
    ... study has found that sex does not increase the chances ... 20 times, contrary to movie mythology. //The study reported that ... use of cocaine could lift the likelihood 20-folds’. ... the first to analyse triggers for heart attacks, including sexual ...
    ... to lower the risk of dementia according to recent research. ... have a lower risk of dementia and Alzheimer’s disease. ... a key factor that is required for the proper functioning ... in this month’s issue of the Archives or Neurology. ...
    ... of AIDS cases reported from strife-torn Afghanistan, have grown from ... of heroin has raised concern amongst health authorities as a ... nation. , ,Anti-narcotics Minister Mohammad Zafar explained how the ... 7,000 in 2003, to 14,000 in 2005. , ,'Forty ...
    Cached Medicine News:Health News:Maiden Quintuple Kidney Transplant Sets a Record 2Health News:Low Health Literacy Is The Major Cause For Patient Errors 2
    Open armhole design with Velcro release enables removal without compromising sterile field. Loops attached at shoulders for proper hanging & storage...
    The most comfortable and easy to use apron in the industry. This front protection apron comes with a fully adjustable snap-on 5" orthopedic belt to relieve weight off your shoulders. Velcro strap acr...
    Six inch wide elastic belt transfers the apron weight off the shoulders. 0.5mm front and 0.25mm back with a generous overlap for double protection. Shoulder pads included. Also available without wide...
    Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
    Medicine Products: